chr6-57210299-G-A
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PVS1_StrongPM2PP5
The ENST00000468148.6(RAB23):c.82C>T(p.Arg28Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000372 in 1,613,458 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
ENST00000468148.6 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAB23 | NM_016277.5 | c.82C>T | p.Arg28Ter | stop_gained | 2/7 | ENST00000468148.6 | NP_057361.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAB23 | ENST00000468148.6 | c.82C>T | p.Arg28Ter | stop_gained | 2/7 | 1 | NM_016277.5 | ENSP00000417610 | P1 | |
RAB23 | ENST00000317483.4 | c.82C>T | p.Arg28Ter | stop_gained | 2/7 | 1 | ENSP00000320413 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152070Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251340Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135836
GnomAD4 exome AF: 0.0000397 AC: 58AN: 1461388Hom.: 0 Cov.: 31 AF XY: 0.0000344 AC XY: 25AN XY: 727016
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152070Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74260
ClinVar
Submissions by phenotype
RAB23-related Carpenter syndrome Pathogenic:2Uncertain:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Genetics and Molecular Pathology, SA Pathology | Mar 02, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 20, 2017 | The RAB23 c.82C>T (p.Arg28Ter) stop-gained variant has been reported in one study and is found in two brothers with Carpenter syndrome with the p.Arg28Ter and p.Leu145Ter variants on a complex allele. These variants are on the maternal allele and are in trans with p.Leu145Ter on the paternal allele (Jenkins et al. 2011). The clinically unaffected mother was confirmed to be a carrier of the complex allele. Control data are unavailable for this variant, which is reported at a frequency of 0.000025 in the Total population in the Exome Aggregation Consortium. Due to the potential impact of stop-gained variants, the p.Arg28Ter variant is classified as a variant of unknown significance but suspicious for pathogenicity for Carpenter syndrome. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
RAB23-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 17, 2024 | The RAB23 c.82C>T variant is predicted to result in premature protein termination (p.Arg28*). This variant has been reported in six individuals from three families with Carpenter syndrome (Jenkins et al. 2011. PubMed ID: 21412941; Ben-Salem et al. 2013. PubMed ID: 23599695; Lodhia et al. 2021. PubMed ID: 33368989). In two of those individuals from one family, the c.434T>A and c.82C>T variant were reported to be on the same allele (cis orientation) with a nonsense variant on the other allele (Jenkins et al. 2011. PubMed ID: 21412941). In another family, both parents were heterozygous for the c.82C>T variant and the child with Carpenter syndrome was homozygous for the c.82C>T variant (Lodhia et al. 2021. PubMed ID: 33368989). Chain-terminating variants in RAB23 are expected to be pathogenic. Taken together, this variant is interpreted as pathogenic. - |
Carpenter syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 31, 2023 | This sequence change creates a premature translational stop signal (p.Arg28*) in the RAB23 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RAB23 are known to be pathogenic (PMID: 17503333, 21412941). This variant is present in population databases (rs765443042, gnomAD 0.007%). This premature translational stop signal has been observed in individual(s) with Carpenter syndrome, although in one family this variant was shown to be on the same chromosome (in cis) with another pathogenic variant (p.Leu145*) (PMID: 21412941, 23599695). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 280858). For these reasons, this variant has been classified as Pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 06, 2023 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Reported previously in two siblings with Carpenter syndrome who harbored a maternally inherited R28X; L145X complex allele in trans with a paternally inherited L145X variant (Jenkins et al., 2011); This variant is associated with the following publications: (PMID: 23599695, 21412941, 33368989) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at